Michael Narkewicz, MD
Professor, Pediatrics-Gastroenterology, Hepatology and Nutrition

Professor of Pediatrics
Associate Dean for Health Affairs, Children's Hospital
Executive, Provider Strategic Partnerships
Clinic (720) 777-6669
Print Profile
Email Profile
Featured Provider Photo

Gender: Male
Languages: English, French
Department, Section/Division: Pediatrics-Gastroenterology, Hepatology and Nutrition

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave
Aurora, CO 80045
720-777-1234
More providers at this location

Hospital Affiliation
  • Children's Hospital Colorado
  • Saint Joseph Hospital

Specialty Information

Specialties
  • Pediatrics - Pediatric Gastroenterology, Board Certification (1990,2016)
  • Pediatrics - Pediatric Transplant Hepatology, Board Certification (2007,2017)
  • Pediatrics, Board Certification (1988)
Conditions & Treatments
  • Digestive System
  • Gastroenterology (Stomach, Bowel, General GI Problems)
  • Hepatology (Liver Disorders)
  • Surgery
  • Liver Transplant Surgery
Clinical Interest for Patients
I am nationally recognized for my expertise in pediatric hepatology and liver transplantation and cystic fibrosis liver disease. I have additional interests in chronic viral hepatitis, pediatric acute liver failure and chronic pancreatitis. I work closely with patients and families to find the best approaches to care to meet their needs.

Volunteer Activities
Round Up River Ranch volunteer physician. Medical Advisory Committee: Round Up River Ranch Chair, Medical Advisory Committee: American Liver Foundation

Education & Training

Medical Schools:
  • MD, University of Vermont College of Medicine (1983)

Undergraduate Schools:
  • AB, Dartmouth College (NH) (1979)

Residency Program:
  • University of Colorado, Pediatrics (1986)

Fellowships:
  • University of Colorado, Pediatric Gastroenterology (1989)

Recognition & Awards

  • Top Doctor in Denver, Pediatric Transplant Hepatology, 5280 Magazine (2019)
  • Top Doctor in Denver, Pediatric Transplant Hepatology, 5280 Magazine (2018)
  • Distinguished Service Award, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (2018)
  • Top Doctor in Denver, Pediatric Transplant Hepatology, 5280 Magazine (2017)
    Voted a 5280 best doctor by my peers in response to the question, "Which physician would you trust to treat you and your family?"
  • Top Doctor in Denver: Pediatric Transplant Hepatology, 5280 Magazine (2016)
  • Top Doctor in Denver: Pediatric Transplant Hepatology, 5280 Magazine (2015)
  • 5280 Top Doctors of Denver: Pediatric Gastroenterology and Pediatric Transplant Hepatology, 5280 Magazine (2014)

Professional Memberships

  • American Academy of Pediatrics (AAP), Fellow AAP
  • American Association for the Study of Liver Disease (AASLD), Fellow Member
  • American Pediatric Society, Member
  • North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), Member

Research & Grants

http://www.ncbi.nlm.nih.gov/pubmed?term="Narkewicz MR" [Author]
Grants
  • Prospective Study of Hepatic US to Predict Cirrhosis In Cystic Fibrosis (2020)
    Cystic Fibrosis Foundation, $1000000
  • A phase 2, open-label , multicenter, multi-cohort study to investigate the safety and efficacy of sofosbuvir/velpatasvir in adolescents and children with chronic HCV-infection (2020)
    Gilead, $100000
  • CFF PUSH cohort analysis using MRI to characterize and predict CF liver disease (2020)
    Cystic Fibrosis Foundation, $23000
  • Pilot study of proteomics and metabolomics as part of the CFLD NET PUSH Longitudinal Study of Cystic Fibrosis Liver Disease. (2020)
    Cystic Fibrosis Foundation, $110000
  • A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function (The PROMISE Study) (2020)
    Cystic Fibrosis Foundation, $100000
  • Long Term Follow-up Registry for Adolescent and Pediatric Subjects Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials (2020)
    Gilead, $10000
  • A Randomized Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Adolescents with Chronic Hepatitis B Virus Infection. (2020)
    Gilead, $20000
Research interests for Patients:
My research focuses on new therapies for children with hepatitis B and C. I lead a large study that is trying to develop tests that will predict which patients with cystic fibrosis are at risk for the development of advanced liver disease

Information for Referring Providers

Clinical Interests for Referring Providers
I am interested in pediatric hepatology, liver transplantation, chronic viral hepatitis, pediatric acute liver failure, cystic fibrosis associated liver disease, and health care delivery.

Research Interest for Referring Providers
My research interests include clinical studies in children with biliary atresia, clinical trials and transmission in chronic viral hepatitis, hematologic and immunologic complications following pediatric liver transplantation, improved diagnosis and treatment of cystic fibrosis-associated liver disease, and clinical trials in acute liver failure.
Clinic Phone: (720) 777-6669
Fax Phone: (720) 777-7277